Janux Therapeutics(JANX)
SAN DIEGO, CABiotechnology
Focus: Janux Therapeutics is a public-stage biotechnology company focused on immunotherapies for cancer, headquartered in San Diego with a clinical-stage pipeline in oncology and autoimmune indications.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
10-4 this month
Stable — net -4 jobs in 30d
5 added, 9 removed. Backfill posture.
Should You Work at Janux Therapeutics?
AI assessmentJanux is a high-risk/high-reward scientific opportunity best suited for researchers prioritizing innovative immunotherapy platform over near-term career stability.
Why Work Here
- 679% R&D intensity signals maximum focus on drug development over commercialization, ideal for scientists seeking pure research impact
- Active hiring across Clinical (5 roles) and R&D (5 roles) indicates expansion phase with direct career advancement opportunities
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$8M
Pipeline & Clinical Trials
JANX011
AutoimmuneClinical Trials (1)
NCT07291323Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.
Phase 1Help build intelligence for Janux Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.